These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 19683825

  • 1. Effects of bed-time insulin versus pioglitazone on abdominal fat accumulation, inflammation and gene expression in adipose tissue in patients with type 2 diabetes.
    Hartemann-Heurtier A, Halbron M, Golmard JL, Jacqueminet S, Bastard JP, Rouault C, Ayed A, Pieroni L, Clément K, Grimaldi A.
    Diabetes Res Clin Pract; 2009 Oct; 86(1):37-43. PubMed ID: 19683825
    [Abstract] [Full Text] [Related]

  • 2. Effects of pioglitazone and metformin on intracellular lipid content in liver and skeletal muscle of individuals with type 2 diabetes mellitus.
    Teranishi T, Ohara T, Maeda K, Zenibayashi M, Kouyama K, Hirota Y, Kawamitsu H, Fujii M, Sugimura K, Kasuga M.
    Metabolism; 2007 Oct; 56(10):1418-24. PubMed ID: 17884455
    [Abstract] [Full Text] [Related]

  • 3. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
    Derosa G, Maffioli P, Salvadeo SA, Ferrari I, Gravina A, Mereu R, Palumbo I, D'Angelo A, Cicero AF.
    Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
    [Abstract] [Full Text] [Related]

  • 4. Diet and exercise reduce low-grade inflammation and macrophage infiltration in adipose tissue but not in skeletal muscle in severely obese subjects.
    Bruun JM, Helge JW, Richelsen B, Stallknecht B.
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E961-7. PubMed ID: 16352667
    [Abstract] [Full Text] [Related]

  • 5. Pioglitazone reduces inflammatory responses of human adipocytes to factors secreted by monocytes/macrophages.
    Permana PA, Zhang W, Wabitsch M, Fischer-Posovszky P, Duckworth WC, Reaven PD.
    Am J Physiol Endocrinol Metab; 2009 May; 296(5):E1076-84. PubMed ID: 19240250
    [Abstract] [Full Text] [Related]

  • 6. [Cardiovascular risk factors and treatment with insulin in type II diabetic patients in whom oral hypoglycemic drugs have failed].
    Calle Pascual AL, Calle Fernández JR.
    Med Clin (Barc); 1993 Jun 26; 101(5):165-7. PubMed ID: 8332008
    [Abstract] [Full Text] [Related]

  • 7. Effect of pioglitazone on insulin sensitivity, vascular function and cardiovascular inflammatory markers in insulin-resistant non-diabetic Asian Indians.
    Raji A, Gerhard-Herman MD, Williams JS, O'connor ME, Simonson DC.
    Diabet Med; 2006 May 26; 23(5):537-43. PubMed ID: 16681563
    [Abstract] [Full Text] [Related]

  • 8. Ultrasonography modifications of visceral and subcutaneous adipose tissue after pioglitazone or glibenclamide therapy combined with rosuvastatin in type 2 diabetic patients not well controlled by metformin.
    Maffioli P, Fogari E, D'Angelo A, Perrone T, Derosa G.
    Eur J Gastroenterol Hepatol; 2013 Sep 26; 25(9):1113-22. PubMed ID: 23524525
    [Abstract] [Full Text] [Related]

  • 9. Soluble CD36 and risk markers of insulin resistance and atherosclerosis are elevated in polycystic ovary syndrome and significantly reduced during pioglitazone treatment.
    Glintborg D, Højlund K, Andersen M, Henriksen JE, Beck-Nielsen H, Handberg A.
    Diabetes Care; 2008 Feb 26; 31(2):328-34. PubMed ID: 18000176
    [Abstract] [Full Text] [Related]

  • 10. Improved vascular function upon pioglitazone treatment in type 2 diabetes is not associated with changes in mononuclear NF-kappaB binding activity.
    Rudofsky G, Reismann P, Grafe IA, Konrade I, Djuric Z, Tafel J, Buchbinder S, Zorn M, Humpert PM, Hamann A, Morcos M, Nawroth PP, Bierhaus A.
    Horm Metab Res; 2007 Sep 26; 39(9):665-71. PubMed ID: 17846974
    [Abstract] [Full Text] [Related]

  • 11. Total and acylated ghrelin levels in type 2 diabetic patients: similar levels observed after treatment with metformin, pioglitazone or diet therapy.
    Kiyici S, Ersoy C, Oz Gul O, Sarandol E, Demirci M, Tuncel E, Sigirli D, Erturk E, Imamoglu S.
    Exp Clin Endocrinol Diabetes; 2009 Sep 26; 117(8):386-90. PubMed ID: 19629933
    [Abstract] [Full Text] [Related]

  • 12. [Expression of omentin in adipose tissues in obese and type 2 diabetic patients].
    Cai RC, Wei L, DI JZ, Yu HY, Bao YQ, Jia WP.
    Zhonghua Yi Xue Za Zhi; 2009 Feb 17; 89(6):381-4. PubMed ID: 19567114
    [Abstract] [Full Text] [Related]

  • 13. Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats.
    Ko GJ, Kang YS, Han SY, Lee MH, Song HK, Han KH, Kim HK, Han JY, Cha DR.
    Nephrol Dial Transplant; 2008 Sep 17; 23(9):2750-60. PubMed ID: 18388116
    [Abstract] [Full Text] [Related]

  • 14. The different mechanisms of insulin sensitizers to prevent type 2 diabetes in OLETF rats.
    Choi SH, Zhao ZS, Lee YJ, Kim SK, Kim DJ, Ahn CW, Lim SK, Lee HC, Cha BS.
    Diabetes Metab Res Rev; 2007 Jul 17; 23(5):411-8. PubMed ID: 17538941
    [Abstract] [Full Text] [Related]

  • 15. Changes of endocrine function of adipose tissue in anorexia nervosa: comparison of circulating levels versus subcutaneous mRNA expression.
    Dolezalova R, Lacinova Z, Dolinkova M, Kleiblova P, Haluzikova D, Housa D, Papezova H, Haluzik M.
    Clin Endocrinol (Oxf); 2007 Nov 17; 67(5):674-8. PubMed ID: 17953628
    [Abstract] [Full Text] [Related]

  • 16. Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone.
    Yao-Borengasser A, Varma V, Bodles AM, Rasouli N, Phanavanh B, Lee MJ, Starks T, Kern LM, Spencer HJ, Rashidi AA, McGehee RE, Fried SK, Kern PA.
    J Clin Endocrinol Metab; 2007 Jul 17; 92(7):2590-7. PubMed ID: 17595259
    [Abstract] [Full Text] [Related]

  • 17. Increased production of proinflammatory cytokines in adipose tissue of patients with end-stage renal disease.
    Roubicek T, Bartlova M, Krajickova J, Haluzikova D, Mraz M, Lacinova Z, Kudla M, Teplan V, Haluzik M.
    Nutrition; 2009 Jul 17; 25(7-8):762-8. PubMed ID: 19539174
    [Abstract] [Full Text] [Related]

  • 18. Pioglitazone treatment increases whole body fat but not total body water in patients with non-alcoholic steatohepatitis.
    Balas B, Belfort R, Harrison SA, Darland C, Finch J, Schenker S, Gastaldelli A, Cusi K.
    J Hepatol; 2007 Oct 17; 47(4):565-70. PubMed ID: 17560678
    [Abstract] [Full Text] [Related]

  • 19. Effect of metformin therapy on plasma adiponectin and leptin levels in obese and insulin resistant postmenopausal females with type 2 diabetes.
    Adamia N, Virsaladze D, Charkviani N, Skhirtladze M, Khutsishvili M.
    Georgian Med News; 2007 Apr 17; (145):52-5. PubMed ID: 17525501
    [Abstract] [Full Text] [Related]

  • 20. Effect of adipose tissue on the sexual dimorphism in metabolic flexibility.
    Sparks LM, Pasarica M, Sereda O, deJonge L, Thomas S, Loggins H, Xie H, Miles JM, Smith SR.
    Metabolism; 2009 Nov 17; 58(11):1564-71. PubMed ID: 19595383
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.